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Cooperation between STAT3 and c-Jun
Suppresses Fas Transcription
(UV) irradiation, viral infection, p53 expression, and che-
motherapeutic agents efficiently increase Fas transcrip-
tion (Tanaka et al., 1994; Owen-Schaub et al., 1995;
Vladimir N. Ivanov,* Anindita Bhoumik,*
Mikhail Krasilnikov,* Regina Raz,†
Laurie B. Owen-Schaub,‡ David Levy,†
Curt M. Horvath,§ and Ze’ev Ronaik Leverkus et al., 1997; Muller et al., 1997). Whereas nu-
clear factor-kB (NF-kB) activates Fas transcription*The Ruttenberg Cancer Center
Mount Sinai School of Medicine (Chan et al., 1999), p38 attenuates NF-kB effects, which
result in the suppression of Fas expression (Ivanov andNew York, New York 10029
†Molecular Oncology and Immunology Program Ronai, 2000). While constitutive and inducible regulatory
pathways govern the level of Fas transcription, theNew York University School of Medicine
New York, New York 10016 mechanisms underlying the loss of Fas cell surface ex-
pression in human tumors are poorly understood. In‡Division of Biomedical Sciences
University of California this study, we demonstrate that downregulation of Fas
expression in human melanoma-derived cell lines is me-Riverside, California 92521
§ Immunobiology Center diated by Stat3 cooperation with c-Jun.
Signal transducers and activators of transcriptionMount Sinai School of Medicine
New York, New York 10029 (STAT) proteins are dual-function molecules that can
be activated by diverse extracellular stimuli to transmit
signals from the cell surface to the nucleus and directly
participate in gene regulation (Ihle, 1995; Darnell, 1997).Summary
Activation of Stats results in the expression of genes that
control critical cellular functions (reviewed in Bowman etDecreased Fas expression during tumor progression
often results in a loss of Fas-ligand (FasL)-mediated al., 2000; Bromberg and Darnell, 2000). An increasing
number of tumor-derived cell lines as well as samplesapoptosis. Human and mouse melanoma exhibit an
inverse correlation between the degree of Fas cell from human cancers contain constitutively activated
Stat proteins, which in most cases are Stat3 and Stat5surface expression, tumorigenicity, and metastatic
capacity. The expression of dominant negative Stat3 (Gouilleux-Gruart et al., 1996; Chai et al., 1997; Garcia
et al., 1997; Garcia and Jove, 1998).or c-Jun in melanoma cells efficiently increased Fas
expression and sensitized cells to FasL-induced apo- Stat3 elicits transcriptional signals as a dimer and
also via its interaction with c-Jun (Zhang et al., 1999).ptosis. Stat31/2 as well as c-Jun2/2 cells exhibited in-
creased Fas cell surface expression and higher sensi- Similarly, the association of Stat1 with SP1 (Look et al.,
1995) and of Stat5 with glucocorticoid receptor (Stocklintivity to FasL-mediated apoptosis. Suppression of Fas
expression by Stat3 and c-Jun is uncoupled from et al., 1996) or CCAAT-enhancer binding protein (cEBP)
(Delphin and Stavnezer, 1995) contribute to Stat-medi-Stat3-mediated transcriptional activation. Our find-
ings indicate that Stat3 oncogenic activities could also ated transcription. Stats have also been implicated in
suppression of target genes; interferon-g suppressionbe mediated through its cooperation with c-Jun, re-
sulting in downregulation of Fas surface expression, of c-myc in wild-type mouse embryo fibroblasts is Stat1
dependent (Ramana et al., 2000).which is implicated in the tumor’s ability to resist ther-
apy and metastasize. A constitutively active form of Stat3 is capable of
immortalizing fibroblasts and causes cellular transfor-
mation (Bromberg et al., 1999). Among Stat target genesIntroduction
that are associated with oncogenesis through regulation
of cell cycle progression and/or apoptosis are Bcl-xLFas (CD95/Apo-1) and Fas-ligand (FasL) are comple-
mentary receptor-ligand proteins that play central roles (Catlett-Falcone et al., 1999a), cyclin D1 (Bromberg et
al., 1999), p21WAF1/CIP1 (Chin et al., 1996; Ouchi et al., 2000),in regulating programmed cell death. Upon interaction
with FasL, Fas forms a complex with the Fas-associated and c-myc (Bromberg et al., 1999).
The notorious resistance of melanoma cells to radia-death domain protein (FADD), which directly binds and
activates caspase-8, resulting in the induction of apo- tion and chemical-induced apoptosis (reviewed in Chin
et al., 1998; Sauter and Herlyn 1998), which inverselyptosis (reviewed in Nagata, 1999). Impaired Fas signal-
ing is frequently observed during tumor progression and correlates with the level of Fas cell surface expression,
prompted us to explore further the mechanisms underly-has been attributed in most cases to downregulation of
Fas expression. Loss of Fas function has been impli- ing suppression of Fas cell surface expression. Here,
we demonstrate that the combined activity of Stat3 andcated in increased resistance of tumors to apoptosis
induced by chemical and physical stimuli, as well as in c-Jun mediates suppression of Fas transcription.
the acquisition of the metastatic phenotype (Hug, 1997;
Owen-Schaub et al., 1998; Shin et al., 1999; Mottolese Results
et al., 2000). Although Fas is constitutively expressed in
a variety of cell types (Leithauser et al., 1993), ultraviolet Fas Cell Surface Expression Inversely Correlates with
Melanoma Resistance to UV irradiation
Analysis of cell surface Fas expression in six melanoma-k To whom correspondence should be addressed (e-mail: zeev.
ronai@mssm.edu). derived cell lines (OM431, FEMX, and HHMSX are highly
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Figure 1. UVC-Induced Apoptosis of Human Melanoma LU1205 Cells Is Fas Dependent
(a) Cell surface Fas expression was determined by staining with PE-conjugated anti-human Fas antibodies and flow cytometry. Filled histogram
represents nonspecific staining with mouse Ig-PE. Mean fluorescence intensity (MFI) is indicated.
(b) Apoptosis analysis of human melanoma cells irradiated with UVC (60J/m2); the percentage of apoptotic cells at 18, 48, and 72 hr after
treatment is indicated. The effect of antagonistic anti-Fas mAb (which was added to cultures prior to treatment) on the level of apoptosis is
shown in the lower panel.
(c) Sensitivity of melanoma cells that exhibit high (LU1205) or very low (HHMSX) levels of Fas cell surface expression to FasL-mediated
apoptosis (in absence or presence of 10 mg/ml cycloheximide, as indicated). The degree of apoptosis was monitored at the indicated time
points.
metastatic cell lines) revealed an inverse correlation be- expression in the acquisition of resistance to radiation-
induced apoptosis.tween stage (chemical/radiation resistance and meta-
static potential) of the tumor and level of Fas expression
(Figure 1a). For example, whereas the LU1205 late-stage Role of STAT3 and c-Jun in the Regulation
of Fas Transcriptionmelanoma cells exhibited 24% apoptosis 18 hr after
UV irradiation, the more aggressive FEMX melanoma- The presence of three g interferon activation site (GAS)
elements within the Fas promoter prompted us to eluci-derived cell line, which expressed lower levels of Fas
on the cell surface, did not undergo apoptosis at all date the possible contribution of Stat to Fas transcrip-
tion. Because each of the GAS elements on Fas pro-(Figure 1b). These differences can be attributed to the
level of Fas expression, as the addition of antagonistic moter is adjacent to an AP1 site and Stat3–c-Jun
cooperation contributes to Stat3-mediated transactiva-anti-Fas antibodies prior to UV treatment decreased the
degree of UV-induced apoptosis of LU1205 cells (from tion (Zhang et al., 1999), we focused our studies on
Stat3. To determine the possible role of Stat3 in Fas70% to 8%), whereas it had no effect on the FEMX cells
(Figure 1b). To assess further the role of Fas cell surface transcription, we used Stat3b, a spliced form of Stat3a
that attenuates Stat3a transcriptional activities and thusexpression in the sensitivity of the melanoma cells to
undergo apoptosis, we have selected to analyze re- serves as a dominant negative of Stat3a (Bromberg et
al., 1996; Caldenhoven et al., 1996). Forced expressionsponse of LU1205 and HHMSX cells, which express high
(125 MFI) or almost no (9 MFI) Fas, respectively (Figure of Stat3b led to a 4-fold increase in Fas-promoter-driven
luciferase activity, whereas expression of the Stat3a1a), to FasL. In the presence of cycloheximide, FasL
mediated apoptosis in LU1205 but not in the HHMSX construct resulted in a 2-fold decrease (Figure 2a). The
degree of increase in Fas transcription elicited by Stat3bcells (Figure 1c), pointing to the role of Fas cell surface
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Figure 2. Stat3b and TAM67 Upregulate Fas Expression
(a and b) Effect of Stat3 and Stat3b on activity of 21.7 kb Fas-Luc (a) or 3xLy6E-Luc (b) reporter constructs in the presence or absence of
IL-6. The normalized ratio of luciferase activity to b-galactosidase is shown.
(c) Effect of c-Jun, TAM67, Stat3, Stat3b, and their combination on activity of 2460 bp Fas-Luc reporter was carried out as indicated in
Experimental Procedures.
(d) Northern blot analysis of Fas mRNA levels after transient transfection of Stat3b or TAM67 into LU1205 cells. Control cells were transfected
by empty pcDNA3 vector.
(e) RT-PCR analysis of Fas transcripts in two melanoma cell lines that stably express Stat3b or TAM67. Control cells were stably infected
with empty vector. Levels of GAPDH transcripts, which were coamplified, are shown. The numbers reflect the relative intensity of the
corresponding Fas transcript bands as measured via phosphorimager.
(f) LU1205 cells were infected with empty (control), Stat3b, or TAM67 cDNA cloned into retroviral vector (pBabe). A mixed population of
puromycin-resistant cells was assayed for changes in Fas surface expression by staining with anti-Fas-PE mAb followed by flow cytometric
analysis. Filled histogram represents nonspecific (ns) staining with mouse Ig-PE. Empty histograms represent control (empty vector) and
Stat3b- or TAM67-expressing cells, as indicated. The numbers reflect MFI values.
(g) Apoptosis analysis of LU1205 cells that constitutively express Stat3b or TAM67 or empty retroviral vector (control) after treatment with
UVC (60 J/m2) or geldanamycin (0.5 mM) or FasL (10 ng/ml) and cycloheximide (10 mg/ml) as indicated. Cells were stained with Annexin-V-
FITC 18 hr after treatment and analyzed by flow cytometry.
was similar to that seen after interleukin-6 (IL-6) treat- 2b). The latter observation led us to hypothesize that
Stat3 may require cooperation with another transcrip-ment, whereas expression of Stat3a attenuated the
modest effect of interleukin-6 (IL-6) on Fas-Luc activity tion factor(s) to elicit suppression of Fas promoter.
The proximity of an AP1 site to each of the three GAS(Figure 2a). These observations imply that Stat3a nega-
tively regulates Fas transcription. Under the same condi- elements on the Fas promoter led us to determine the
possible contribution of c-Jun alone and in combinationtions, the expression of Stat3a increased GAS-depen-
dent (3xLy6E)-Luc activities and more so after IL-6 with Stat3 to the regulation of Fas transcription. Forced
expression of c-Jun did not affect Fas transcription,treatment, and Stat3b efficiently blocked IL-6-induced
GAS-Luc activity (Figure 2b). These findings suggest probably because of the abundant amount of transcrip-
tionally active c-Jun in late-stage melanoma cells (Iva-that Stat3’s ability to reduce Fas-Luc activity is uncou-
pled from the conventional Stat3-dependent expression nov and Ronai, 1999). Melanoma cells that express
TAM67, a dominant negative form of c-Jun (Brown etof a multimerized GAS element reporter gene (Figure
Molecular Cell
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al., 1994), revealed a 3-fold increase in Fas-Luc activity, transcription (Figure 3a). Stat3b caused an over 3-fold
increase when transfected alone and slightly augmentedwhich was attenuated upon coexpression of Stat3 (Fig-
ure 2c). These observations suggest that c-Jun may the increase mediated by TAM67. The ability to rescue
Fas transcription by inhibition of Stat3 or c-Jun wasalso contribute to the suppression of Fas transcription.
Forced expression of Stat3b increased Fas-Luc activity, also reflected at the level of Fas cell surface expression
where transient expression of TAM67 or Stat3b alonewhich was further elevated upon coexpression of Stat3b
and TAM67 (Figure 2c). These data point to the possible caused a noticeable change in the percentage of cells
that express low levels of Fas on their surface (data notcooperation of c-Jun and Stat3 in the downregulation
of Fas transcription. These observations were made us- shown). Similarly, HHMSX cells that were infected with
retrovirus carrying either Stat3b or TAM67 exhibit a 5- toing a Fas promoter fragment (2460), which contains one
GAS, AP1, and NF-kB sites and which represents the 7-fold increase in Fas cell surface expression (Figure
3b). Constitutive expression of TAM67 or Stat3b in WM4activities seen by the full-length 1.7 kb promoter region
(data not shown; Chan et al., 1999). melanoma cells also increased Fas transcription (data
not shown) and cell surface expression (Figure 3c).Northern blot analysis of RNA extracted from the cells
that were transiently transfected with either TAM67 or Exposure of WM4 cells that constitutively express either
TAM67 or Stat3b to FasL caused an approximatelyStat3b revealed an increase in Fas mRNA levels (Figure
2d). The extent of this effect is probably underestimated 2-fold increase in the level of apoptosis (Figure 3d).
These data demonstrate that increased Fas cell surfacebecause of the limited efficiency of transient transfec-
tion. Reverse transcription-polymerase chain reaction expression upon inhibition of either c-Jun or Stat3 effi-
ciently sensitize melanoma cells to FasL-mediated apo-(RT-PCR) confirmed an increase of Fas mRNA levels
in two melanoma-derived cell lines that express either ptosis.
TAM67 or Stat3b (Figure 2e). These data demonstrate
that the changes seen in the Fas-Luc assays are re- Stat3/c-Jun-Dependent Fas Expression in Mouse
flected at the level of Fas transcripts. Melanoma-Derived Cells
To elucidate further Stat3 and c-Jun effects on Fas To assess further the role of c-Jun and Stat3 in Fas
expression, melanoma cells were subjected to retrovi- expression, we used a mouse melanoma model in which
rus-mediated infection with either Stat3b or TAM67, and the degree of tumorigenicity and metastatic potential
a mixed population of clones that constitutively express inversely correlates with level of Fas cell surface expres-
these constructs was further characterized. A clear in- sion (Owen-Schaub et al., 1998). SW1 cells are among
crease in the level of Fas cell surface expression was the more metastatic and exhibit a marked loss of Fas
observed in both the TAM67- and Stat3b-expressing cell surface expression when compared with the K1735p
cells (Figure 2f). Similarly, analysis of LU1205 cells that or C-19 tumors (Figure 4b) (Owen-Schaub et al., 1998).
were transiently transfected with these expression vec- A decrease in Fas cell surface expression coincides with
tors and green fluorescent protein (GFP) demonstrated the increased Stat3 expression (Figure 4a). Infection of
a noticeable increase of Fas surface levels in Stat3b- SW1 cells with retroviral constructs for either Stat3b or
expressing cells, which was comparable with the effect TAM67 led to a marked increase in Fas cell surface
of TAM67 (60 to 110 units of MFI; data not shown). expression (Figure 4c) and sensitized them to FasL-
These findings confirm that Stat3- and c-Jun-mediated mediated apoptosis (Figure 4d). These observations es-
changes at the level of Fas transcription result in a coor- tablish the role of Stat3 and c-Jun in downregulation of
dinated decrease in the cell surface protein expression Fas cell surface expression in mouse melanomas.
level.
We next monitored changes in the fraction of Stat3b- Increased Fas Expression in Stat31/2 Cells
or TAM67-expressing melanoma cells that underwent We have next examined the expression of Fas in embry-
apoptosis upon treatment with either FasL, UV, or gelda- onic stem (ES) as well as in mouse fibroblast cells lacking
namycin. Melanoma cells that express either Stat3b or one of the Stat3 alleles (Raz et al., 1999, and unpublished
TAM67 exhibited a 5- to 8-fold increase in the degree observations). ES-Stat31/2 cells express approximately
of early apoptosis in response to FasL. UV irradiation 50% of the Stat3 protein found in ES-Stat31/1 cells (Fig-
or geldanamycin treatment also caused greater degree ure 5a). ES-Stat31/2 cells exhibited a 70% increase in
of apoptosis (2- to 6-fold) in cells that expresses higher basal Fas promoter activities when compared with the
cell surface Fas, because of the suppression of Stat3 activity seen in ES-Stat31/1 cells (Figure 5b). This obser-
or c-Jun (Figure 2g). These observations suggest that vation points to an inverse correlation between Stat3
attenuating Stat3 or c-Jun activity efficiently sensitizes expression and Fas transcription. Stat3b elicited a 3-fold
melanoma cells to FasL and DNA-damaging, agent- increase in Fas-Luc activity in ES-Stat31/1 cells, as com-
induced apoptosis. pared with the less than 2-fold increase seen in the ES-
Stat31/2 cells. Fas promoter mutated within the GAS
element exhibited a 5-fold increase in transcriptionalInhibition of STAT3 or c-Jun Rescues Fas Expression
in Fas-Negative Melanoma Cells activity in the Stat31/1 cells, as compared with a 2-fold
increase in Stat31/2 cells (Figure 5b). This finding estab-The human melanoma cell line HHMSX exhibits almost
undetectable levels of Fas cell surface expression (Fig- lishes the relationship between Stat3 expression and
suppression of Fas promoter through the GAS element.ure 1a) and is resistant to FasL treatment (Figure 1c).
Forced expression of TAM67 in the HHMSX cells led to Coexpression of GAS mutant Fas-Luc and Stat3b did not
cause a further increase in the degree of transcriptionala 5-fold increase in the level of Fas promoter-mediated
STAT3 and c-Jun Suppress Fas Receptor Expression
521
Figure 3. Stat3b and TAM67 Rescue Fas Expression in HHMSX and Upregulate Fas Levels in WM4 Melanoma Cells
(a) Effect of TAM67 and Stat3b on activity of 21.7 kb Fas-Luc reporter in HHMSX cells.
(b) Flow cytometric analysis of HHMSX cells infected with retrovirus carrying Stat3b or TAM67 or empty (control) expression vectors. The
filled histogram represents nonspecific (Ig-PE) staining, whereas the open histogram represents the level of Fas. The percentage values
represent the percentage of Fas-positive cells.
(c) MFI of Fas cell surface expression in WM4 cells, which stably expresses Stat3b or TAM67, or empty pcDNA3 vector (control) is shown.
(d) Apoptosis of WM4 cells that constitutively express TAM67 or Stat3b or empty vector (control) 36 hr after treatment with FasL (50 ng/ml)
and cycloheximide (10 mg/ml).
activities seen by GAS mutant Fas-Luc alone, further Increased Fas Cell Surface Expression
in c-Jun2/2 Cellssupporting the finding that Stat3 suppression of Fas is
mediated through the GAS element. Given the role of c-Jun in the suppression of Fas cell
surface expression, we have next elucidated the levelDifferences in the degree of endogenous Fas expres-
sion were also reflected at the level of Fas cell surface of Fas cell surface expression in c-Jun2/2 fibroblasts
(Wisdom et al., 1999). c-Jun2/2 fibroblasts exhibit aexpression. Seventy percent of ES- Stat31/2 cells were
positive for cell surface Fas expression compared with marked increase (180 vs. 100 MFI) in Fas cell surface
expression (Figure 6a). This finding points to an inverse28% of the Stat31/1 cells (Figure 5c).
Similar to the finding in the ES Stat31/2 cells, mouse correlation between c-Jun and Fas expression. Differ-
ences in Fas expression coincided with sensitivity toembryo fibroblasts (MEFs) of Stat31/2 mice exhibit a
marked increase in Fas cell surface expression when FasL-mediated apoptosis; 41% of c-Jun1/1 cells under-
went apoptosis as compared with 83% of the c-Jun2/2compared with the parent MEF (Figure 5d). Forced ex-
pression of Stat3 efficiently reduced the level of Fas, cells (Figure 6b). Forced expression of c-Jun in the
c-Jun2/2 fibroblasts efficiently reduced the level of Fasalmost to the level seen in the wild-type MEF cells.
Sensitivity of Stat31/2 fibroblasts to FasL and cyclohexi- cell surface expression (from 92 to 59 MFI where 54 is
the basal level seen in c-Jun1/1 cells; Figure 6c). Thesemide-mediated apoptosis coincided with the degree of
Fas cell surface expression (Figure 5e). The inverse cor- data provide additional support for the role of c-Jun in
suppression of Fas transcription. Interestingly, forcedrelation between Stat3 expression and Fas transcription
as found in Stat31/2 cells provides genetic evidence for expression of Stat3b led to a further increase in Fas
surface expression, suggesting that in the absence ofthe role of Stat3 in downregulation of Fas transcription.
Molecular Cell
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Figure 4. Stat3- and c-Jun-Dependent Fas Surface Expression in Mouse Melanoma Tumors Inversely Correlates with Sensitivity to FasL-
Mediated Apoptosis
(a) Western blot analysis of Stat3 expression in mouse melanoma-derived cells of which K1735p is nonmetastatic and exhibit the lower degree
of tumorigenicity. C-19 has intermediate tumorigenicity but is nonmetastatic, and both SW1 and ml1 are highly tumorigenic and metastatic
(Owen-Schaub et al., 1998).
(b) Level of Fas cell surface expression on each of the mouse melanoma tumor-derived cells.
(c) Retroviral-mediated infection of TAM67 or Stat3b or empty retroviral vector led to marked increase in Fas cell surface expression (open
histograms). The percentage of Fas-positive cells is indicated.
(d) Apoptosis of SW1 cells 36 hr after treatment with FasL (50 ng/ml) and cycloheximide (1 mg/ml).
c-Jun, Stat3 may cooperate with other transcription fac- requires cooperation with another transcription fac-
tor(s). Upon Stat3b expression, Fas reporter mutated ontors that bind to the AP1 site (that is, ATF2) to elicit
a certain degree of Fas suppression, which could be the GAS element no longer exhibited an increase in
transcriptional activities, suggesting that the GAS ele-alleviated upon Stat3b expression. Transient reconstitu-
tion of c-Jun expression in the c-Jun2/2 cells was capa- ment is required to relieve Fas suppression by endoge-
nous Stat3. Expression of TAM67 led to an over 9-foldble of reducing the degree of FasL-mediated apoptosis
(from 50 to 31%; Figure 6d). Expression of c-Jun in increase in luciferase activity mediated by Fas promoter
that had been mutated within the GAS element (FigureJun1/1 cells did not alter degree of FasL-mediated apo-
ptosis (27%) (data not shown). These results provide 7a). The marked increase of Fas-Luc activities under
conditions in which neither Stat3 (GAS mutated site)genetic support for the role of c-Jun in the suppression
of Fas expression. nor Jun (TAM67 effect) is available suggests that c-Jun
cooperation with Stat3 is required to mediate suppres-
sion of Fas transcription.Stat3 and c-Jun Affect Fas Promoter Activities
Mutation within the AP1 site on the Fas promotervia GAS and AP1 Elements
caused a modest increase in basal Fas transcriptionTo characterize inhibition of Fas transcription by Stat3,
and abrogated the effect of TAM67. These findings con-we mutated the GAS elements within the Fas promoter
firm that c-Jun effects on Fas promoter are mediatedsequences linked to the luciferase reporter gene. Both
through the AP1 site and suggest that c-Jun alone mayStat3b and TAM67 increased luciferase activity medi-
not be sufficient to mediate suppression of Fas tran-ated from the Fas promoter region, although Stat3b was
scription. Stat3b was capable of eliciting an over 10-foldthree times as effective (Figure 7a). A mutation within
increase in AP1-mutated Fas promoter activities (Figurethe single GAS element caused a modest increase in
7a). Deletion of both AP1 and GAS elements from theFas-Luc activity. The same mutant exhibited a 5-fold
Fas promoter region revealed a higher increase in Fasincrease in Fas-Luc activity in the ES-Stat31/1 cells (Fig-
ure 5b), implying that in these melanoma cells, Stat3 transcription than observed upon mutating either the
STAT3 and c-Jun Suppress Fas Receptor Expression
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Figure 5. Stat3 Expression Inversely Correlates with Levels of Fas in Stat31/2 ES and Mouse Embryo Fibroblast Cells
(a) Western blotting of total cell extracts (70 mg) from ES Stat31/1 and Stat31/2 cells using anti-Stat3, phospho-Tyr705, or anti-Fas Abs.
(b) Stat31/1 or Stat31/2 ES cells were transiently transfected with the 2460 Fas promoter-Luc (0.5 mg) or with a mutated variant of this construct
(GASmut) in the presence of 0.25 mg of pCMV-b-gal. The normalized ratio of luciferase activity to b-galactosidase is shown.
(c) Cell surface expression of Fas in ES was determined by anti-Fas-PE mAb and analyzed using flow cytometry. The percentage of Fas-
positive cells is indicated.
(d) Level of Fas cell surface expression in Stat31/2 mouse embryo fibroblasts 36 hr after cotransfection of pGFP and mock or pGFP 1 Stat3.
(e) Apoptosis of Stat31/2 or Stat31/1 MEF 36 hr after treatment with FasL (50ng/ml) and cycloheximide (1 mg/ml).
GAS or the AP1 sites (Figure 7a). Neither TAM67 nor expression of Stat3 that has been mutated to enable
its constitutive dimerization (Stat3-C) (Bromberg et al.,Stat3b was able to augment the level of Fas transcription
in the absence of AP1 and GAS elements, further sup- 1999) increased GAS-Luc (Figure 7c), as well as Fas
promoter activities (Figure 7b). The forms of Stat3 thatporting the role of c-Jun and Stat3 in suppression of
Fas transcription via the corresponding binding sites. were able to increase Fas-Luc transcription—Stat3b,
Stat3-C, and QC1—differ from wild-type Stat3 in their
abilities to form certain protein interactions. Stat3-C isStat3 Suppression of Fas Transcription
locked into a homodimeric configuration, and QC1 can-Is Uncoupled from Its Transactivation
not bind c-Jun. These findings suggest that Stat3 hetero-of Multimerized GAS Elements
merization is one of the parameters that confer Stat3’sTo analyze Stat3-mediated suppression of Fas tran-
ability to mediate suppression of Fas promoter activities.scription, a mutant form of Stat3 that is no longer capa-
These observations also imply that under conditions inble of associating with c-Jun was used. Forced expres-
which such association is abolished, Stat3 can elicit asion of Stat3 mutated within its c-Jun binding site (Stat3
positive signal for Fas transcription. Although bothQC-1) (Zhang et al., 1999) abolished its ability to mediate
Stat3b and TAM67 effectively elevate Fas-Luc activities,Fas suppression and was able to increase Fas transcrip-
neither is able to elicit a similar increase in GAS-Luctional activities (Figure 7b). This observation further sup-
activities (Figure 7c). These findings further demonstrateports the need for Stat3 cooperation with c-Jun to medi-
ate suppression of Fas transcription. Interestingly, that the suppressive effects of Stat3 and c-Jun on Fas
Molecular Cell
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Figure 6. Jun2/2 Fibroblasts Exhibit Higher Fas Cell Surface Expression and Sensitivity to FasL-Mediated Apoptosis
(a) Analysis of Fas cell surface expression in Jun1/1 and Jun2/2 mouse embryo fibroblasts. The numbers reflect MFI.
(b) Apoptosis of Jun2/2 vs. Jun1/1 fibroblasts 36 hr after treatment with cycloheximide (1 mg/ml) and FasL at concentrations of 25 ng/ml (1) or
50 ng/ml (2).
(c) Level of Fas cell surface expression in Jun2/2 cells that were cotransfected with c-Jun or Stat3b and pGFP.
(d) Level of apoptosis 36 hr after FasL (50 ng/ml) and cycloheximide (1 mg/ml) treatment of Jun2/2 fibroblasts that were transfected with empty
vector and pGFP or c-Jun and pGFP.
promoter are uncoupled from the regulation of the iso- direct evidence for the presence of the Stat3-Jun com-
plex and for its specific association with the GAS-AP1lated GAS elements.
target sequences present on the Fas promoter.
STAT3-Jun Complex Is Bound to Fas
Promoter Sequences Recruitment of c-Jun to Fas Promoter
Is Modified after UV IrradiationWe next monitored the possible association of Stat3
with c-Jun in human melanoma cell lines. Immunopre- Further confirmation for c-Jun and Stat3 binding to the
Fas promoter was obtained in vivo via ChIP assays oncipitation of nuclear extracts with antibodies to Stat3
followed by immunoblot analysis using antibodies to chromatin samples from untreated and UV-irradiated
melanoma cells. Both Stat3 and c-Jun were found inc-Jun identified Stat3–c-Jun complexes in both mela-
noma cell lines (Figure 7d). Incubation of nuclear ex- association with Fas promoter in nontreated cells, con-
sistent with the notion that both transcription factorstracts prepared from nontreated melanoma cells with
biotinylated oligonucleotides bearing the GAS-AP1 se- are bound to Fas promoter under conditions in which
Fas expression is suppressed. Decreased binding ofquences as present on the Fas promoter detected both
Stat3 and c-Jun as Fas promoter-bound proteins (Figure Stat3 to Fas promoter was seen as early as 2 hr and
more so 6 hr after UV treatment. Within 6 hr after UV7e, panel I). A mutation on both GAS and AP1 elements
efficiently abolished the binding of both Stat3 and c-Jun irradiation, binding of c-Jun was no longer apparent
(Figure 7f). Decreased c-Jun binding to the Fas promoter(Figure 7e, panel II; compare wild type with DM lanes).
Binding of Stat3 or c-Jun to Fas promoter sequences, sequences coincided with transient upregulation of Fas
expression (Figure 7f, panel III). The change in c-Junin which either GAS or AP1 sites were mutated, revealed
a substantial decrease in the binding of the respective and Stat3 binding to Fas promoter sequences after UV
treatment, which mediates apoptosis through elevatedtranscription factor (Figure 7e). These findings provide
STAT3 and c-Jun Suppress Fas Receptor Expression
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Figure 7. Both AP1 and GAS Elements Are Required for Efficient Suppression of Fas Transcription
(a) LU1205 cells were transiently transfected with indicated constructs. After 14 hr, cells were analyzed for luciferase and b-galactosidase
activity. The normalized ratio of luciferase activity to b-galactosidase is shown.
(b) The 2460 Fas-Luc construct was used with the empty vector TAM67 or with different mutated forms of Stat3, including Stat3b and
Stat3QC-1, which lost the ability to interact with c-Jun and Stat3-C, which represented a permanently active form of Stat3.
(c) GAS reporter construct (3xLy6E-Luc) was used for transfection under conditions described in (b).
(d) Stat3 interacts with c-Jun and binds to GAS/AP1 sequences in human melanomas (I) Nuclear extracts (400 mg) from melanoma LU1205
and HHMSX cells prepared prior (2) or at the indicated time points after UVC (1) were immunoprecipitated with anti-Stat3 Ab. Immunoprecipi-
tates were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by Western blotting with indicated Abs. C1 and
C2 represent whole cell extract and 20% input of nuclear extracts of LU1205 cells, respectively. (II) Western blotting of nuclear extracts (70
mg) of melanoma LU1205 and HHMSX cells (UVC1 or UVC2) using anti-Stat3 or anti-c-Jun Abs.
(e) Biotinylated oligonucleotides containing GAS-AP1-element sites as present on the Fas promoter (Fas-oligo) in wild-type or mutant (on
AP1, GAS, or double mutants [DM], as indicated) were incubated with nuclear proteins of LU1205 cells. Biotinylated oligonucleotide-bound
proteins were captured on avidin agarose beads and were washed, and GAS-AP1-bound proteins were eluted and analyzed on Western
blotting with the indicated Abs.
(f) Panel I, ChIP assays were carried out on chromatin that was immunoprecipitated with antibodies to Stat3 or c-Jun from control or UV-
treated cells at the indicated time points. Shown is a Fas promoter fragment amplified by PCR from each of the ChIP samples. Control IP
was performed with IgG (data not shown) or nonrelevant antibodies to CD3. Amplification of genomic DNA is shown (gDNA). Panel II shows
the Western blot of input as well as immunoprecipitated Stat3 and c-Jun from nuclear extracts. Panel III depicts Western blot analysis of Fas
expression.
Fas expression (Figure 1b), coincides with increased onstrated in several human and mouse melanoma cell
lines. Important confirmation to our findings comes fromFas expression, which is required for the sensitization
of these melanoma cells to UV-induced cell death (Iva- the use of Stat31/- and c-Jun2/2 cells that exhibit elevated
Fas expression, which could be reduced upon re-nov and Ronai, 1999), and points to the reversibility of
Stat3-mediated suppression of Fas transcription. expression of Stat3 or c-Jun, respectively.
Because low Fas expression has been associated
with resistance to therapy, metastatic capacity, andDiscussion
poor prognosis, the finding that Stat3 contributes to
downregulation of Fas transcription highlights a novelThe present study demonstrates that suppression of Fas
transcription and subsequent cell surface expression mechanism for Stat3 oncogenic activities. The suppres-
sion of Fas transcription by Stat3-Jun is uncoupled fromis mediated via cooperation between two oncogenes,
Stat3 and c-Jun. The role of Stat3 and c-Jun in the Stat3 ability to elicit transactivation of traditional GAS
elements bearing promoters. We provide direct evi-suppression of Fas transcription, cell surface expres-
sion, and sensitivity to FasL-elicited apoptosis is dem- dence that Stat3 cooperation with c-Jun is required to
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elicit downregulation of Fas transcription. The require- mouse melanoma tumor-derived cell lines, our study
ment for such cooperation is demonstrated via the use identifies the mechanism underlying the notorious resis-
of the Stat3-QC mutant, which is mutated on its c-Jun tance of melanoma and possibly other tumor types to
docking site (Zhang et al., 1999) and has lost its ability therapy.
to inhibit Fas transcription. Furthermore, mutation of
Experimental ProceduresGAS element on Fas promoter together with inhibition
of c-Jun (or vice versa) was the most efficient means
Cell Linesamong those tested in derepressing Fas-reporter activi-
Human melanoma cells were maintained in culture as previously de-ties. Downregulation of Fas transcription may be aug-
scribed (Ivanov and Ronai, 2000; Ivanov et al., 2000). ES cells E14
mented by additional cellular components, which can (Stat31/1) (Hooper et al., 1987) and E14 clone 3-2 (Stat31/2) were
affect Stat3 and/or c-Jun transcriptional activities. propagated by standard methods on monolayers of mitomycin
Our ChIP data demonstrate that following UV treat- C-treated mouse fibroblasts (Raz et al., 1999). Stat31/2 immortalized
mouse embryo fibroblasts were prepared by standard proceduresment, there is a decrease in Stat3 and a loss of c-Jun
(Aaronson and Todaro, 1968) from mouse embryos heterozygousbound to Fas promoter in vivo, which coincides with
for Stat3, derived from gene-targeted ES cells (Raz et al., 1999).increased Fas transcription and expression and con-
Stat31/2 fibroblasts, c-Jun2/2 fibroblasts, and mouse melanoma
comitant Fas-dependent apoptosis. This finding pro- cells were maintained in Dulbecco’s modified Eagle’s medium sup-
vides important support for the cooperation of c-Jun plemented with 10% fetal bovine serum.
and Stat3 and for the existence of a dynamic regulation
of Stat3/c-Jun recruitment to Fas promoter, which is Plasmid Constructs
required to mediate suppression of Fas transcription Reporter construct 21.7 kb Fas-Luc and 2460 Fas-Luc were pre-
viously described (Chan et al., 1999). Mutations within the GAS orunder relevant physiological conditions. Stat3 coopera-
AP1 site were generated using the Quick Change kit (Stratagene,tion with c-Jun could take place through heterodimeriza-
La Jolla, CA). Primers used to generate mutations within the GAStion of the two proteins or through association of c-Jun
site were GAC AGG AAT GCC CAT TTG TGC TTC GAA CCC TGA
with a dimerized form of Stat3. A dimer form of Stat3 CTC and GAG TCA GGG TTG GAA GCA CAA ATG GGG, within the
has been implicated in the association with c-Jun to AP1 site were CCC ATT TGT GCA ACG AAC CCA AAC TCC TTC
elicit activation of a2-macroglobulin promoter bearing CTC ACC and GGT GAG GAA GGA GTT TGG GTT CGT TGC ACA
AAT GGG. Deletion of the 24bp sequence containing both AP1 andadjacent AP1 and GAS elements (Zhang et al., 1999).
GAS elements was carried out using primers CCC CGG GAC AGGStat3b was also reported to cooperate with c-Jun to
AAT GCC CAC CTC ACC CTG ACT TCT CCC CCTC and GAG GGGenhance a2-macroglobulin promoter activities (Schaefer
GAG AAG TCA GGG TGA GGT GGG CAT TCC TGT CCG GGGG.et al., 1995). The nature of Stat3-Jun-mediated Fas sup-
Primers used to mutate the distal 2677/2669 GAS elements were
pression, as opposed to transactivation of a2-macro- GGT TAA CTG TCC ATT CCA GGT TCG TCT GTG AGC CTC TC and
globulin, could depend on the proximity of GAS and AP1 GAG AGG CTC ACA GAC GAA CCT GGA ATG GAC AGT TAA CC.
elements, as well as the context of adjacent promoter Expression vectors pRcCMV containing Stat3, Stat3 QC1 (L148A),
or Stat3-C were described previously (Bromberg et al., 1999; Zhangsequences. Alternatively, such differences could stem
et al., 1999). The expression plasmid pIRES-Stat3b, which encodesfrom the composition of the overall transcriptional com-
the human Stat3b (Catlett-Falcone et al., 1999b), was kindly pro-plex on the DNA, which was shown to affect strongly
vided by Dr. R. Jove (Moffit Cancer Center, University of South
DNA bending and transcriptional potency in the case of Floria, Tampa, FL). Retroviral vectors for Stat3b or TAM67 were
AP1 (Rajaram and Kerppola, 1997; Chytil et al., 1998; generated by PCR amplification of the corresponding cDNAs, which
Falvo et al., 2000). Equally relevant is the possibility that were subsequently subcloned into the XhoI (Stat3b) or BamHI/EcoRI
(TAM67) sites of the pBabe vector. In all cases, the sequence integ-the response to c-Jun and Stat3 activities is cell/tissue
rity of modified/cloned constructs was confirmed via sequencing.dependent. Whereas Stat3’s ability to elicit transcrip-
tional suppression (pending cooperation with c-Jun) is
Transfection and Luciferase Assayshown in this study, the ability of c-Jun to elicit transcrip-
The luciferase reporter gene containing three GAS elements fromtional suppression was documented for Smad3 (Dennler
the Ly6E gene was previously described (Wen et al., 1995). Transientet al., 2000), p53 (Schreiber et al., 1999), and major histo-
transfection of different reporter constructs (0.5 mg) together with
compatibility complex class I (Howcroft et al., 1993). expression vectors and pCMV-bgal (0.25 mg) into 5 3 105 melanoma
Inhibition of Stat3 and c-Jun efficiently increased Fas cells was performed using Lipofectamine (Life Technologies-BRL,
transcription and cell surface expression, even in mela- Grand Island, NY). Proteins were prepared for bGal and luciferase
analysis 14 hr after transfection. Luciferase activity was determinednoma cells that were near null for Fas expression. In all
using the luciferase assay system (Promega, Madison, WI) and nor-cases, such increases led to a concomitant sensitization
malized based on b-galactosidase levels. Retroviral packaging andof melanoma cells to FasL-induced apoptosis. Reduced
infection carried out as previously described (Morgenstern andFas expression has also been implicated in the meta-
Land, 1990). Infected cultures were subjected to selection in puro-
static capacity of human tumors and was further docu- mycin (1.5 mg/ml), and a mixed population of resistant cells was
mented in the mouse melanoma model (Owen-Schaub analyzed.
et al., 1998). Forced expression of Stat3b or TAM67
efficiently restored Fas expression, sensitized the more Treatment and Apoptosis Studies
aggressive SW1 tumor cells to FasL-mediated apopto- Cells were exposed to UV at a wavelength of 254 nM (C) (UVC) at 60J/
m2 as previously described (Ivanov and Ronai, 1999). Antagonisticsis and reduced SW1 tumor outgrowth at the orthotopic
monospecific antibodies against Fas (clone G254–274; Pharmingen)site in mice (data not shown). The latter are in line with
were added (1–5 mg/ml) 1 hr before UVC treatment. FasL (25–50 ng/the observation that elevated Fas expression in PC3
ml) was used in combination with cycloheximide. Apoptosis was
and LNCAP prostate cell lines reduced tumor outgrowth assessed by quantifying the percentage of hypodiploid nuclei under-
(Takeuchi et al., 1996). going DNA fragmentation (Nicoletti et al., 1991). Surface expression
In pointing to the role of Stat3-Jun cooperation in the of Fas was determined using anti-Fas-PE Ab (Pharmingen). Flow
cytometric analysis was performed on a FACS Calibur flow cyto-constitutive repression of Fas expression in human and
STAT3 and c-Jun Suppress Fas Receptor Expression
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meter (Becton Dickinson, Mountain View, CA) using the CellQuest scriptional control and their impact on cellular function. Oncogene
19, 2468–2473.program.
Bromberg, J.F., Horvath, C.M., Wen, Z., Schreiber, R.D., and Darnell,
Transient Transfection and GFP Assay J.E., Jr. (1996). Transcriptionally active Stat1 is required for the
Melanoma cells (5 3 105) were transiently cotransfected with expres- antiproliferative effects of both interferon alpha and interferon
sion vectors together with marker plasmid encoding GFP (pGFP; 1 mg gamma. Proc. Natl. Acad. Sci. USA. 93, 7673–7678.
and 0.25 mg, respectively) using Lipofectamine (Life Technologies- Bromberg, J., Wrzesczynska, M., Devgan, G., Zhao, Y., Pestell, R.,
BRL). Twenty-four hours after transfection, surface Fas expression Albanese, C., and Darnell, J., Jr. (1999). Stat3 as an oncogene. Cell
in GFP-positive cells was determined by staining with PE-anti-Fas 98, 295–303.
Ab and flow cytometry. For apoptosis studies, cells were irradiated
Brown, P.H., Chen, T.K., and Birrer, M.J. (1994). Mechanism of actionwith UVC (60J/m2) 24 hr after transfection and 18 hr later were
of a dominant-negative mutant of c-Jun. Oncogene 9, 791–799.stained with propidium iodide (PI) and analyzed by flow cytometry.
Caldenhoven, E., van Dijk, T.B., Solari, R., Armstrong, J., Raaimmak-
ers, J.A.M., Lammers, J.W.J., Koenderman, L., and de Groot, R.P.ChIP assays
(1996). STAT3beta, a splice variant of transcription factor STAT3, isThe ChIP assays were based on protocol described by Falvo et al.
a dominant negative regulator of transcription. J. Biol. Chem. 271,(2000). Human melanoma cells (2.5 3 106 cells per 10 cm diameter
13221–13227.plate) were exposed to UV irradiation (60J/m2), and cells were fixed
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